News

Public sector must develop drugs for neglected diseases

BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7339.698/b (Published 23 March 2002) Cite this as: BMJ 2002;324:698
  1. Gavin Yamey
  1. Oakland

    Western society's decision to leave drug development in the hands of the private sector has led to a crisis for the world's poor, because the private sector has failed to develop or distribute drugs to treat infectious diseases in the poorest regions of the world. A new public sector initiative is urgently needed to …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe